SRP4975

IL-24 human

recombinant, expressed in Saccharomyces cerevisiae, ≥98% (SDS-PAGE), ≥98% (HPLC)

Manufacturer: Sigma Aldrich

Synonym(S): C49A, FISP, IL-24, IL10B, MDA7, ST16

Select a Size

Pack Size SKU Availability Price
10 μG SRP4975-10-μG In Stock ₹ 38,716.80

SRP4975 - 10 μG

₹ 38,716.80

In Stock

Quantity

1

Base Price: ₹ 38,716.80

GST (18%): ₹ 6,969.024

Total Price: ₹ 45,685.824

biological source

human

recombinant

expressed in Saccharomyces cerevisiae

Assay

≥98% (HPLC)≥98% (SDS-PAGE)

form

lyophilized

mol wt

~19.5 kDa

packaging

pkg of 10 μg

impurities

endotoxin, tested

NCBI accession no.

Q13007

shipped in

wet ice

storage temp.

−20°C

Description

  • General description: IL24 is a member of the IL10 family of cytokines. It was identified as a gene induced during terminal differentiation in melanoma cells. IL-10B encoded can induce apoptosis selectively in various cancer cells. Overexpression IL-24 leads to elevated expression of several GADD family genes, which correlates with the induction of apoptosis. The phosphorylation of mitogen-activated protein kinase 14 (MAPK7/P38), and heat shock 27kDa protein 1 (HSPB2/HSP27) are found to be induced by this gene in melanoma cells, but not in normal immortal melanocytes. Alternatively spliced transcript variants encoding distinct isoforms have been reported. The glycosylation is essential for activity of IL-24. Functionally, IL-24 has diverse activities. At low concentrations, it induces type I proinflammatory cytokines such as IFN-γ, IL-1β, IL-12 and TNF-α. At high concentration, it is a strong inducer of apoptosis in tumor cells, but not normal cells. mda-7/IL-24 is being hailed as a ‘magic bullet′ for cancer gene therapy. Recombinant human Il-24 produced in yeast is a single, glycosylated, polypeptide chain containing 158 amino acids and having a molecular mass of 18 kDa. As a result of glycosilation, the protein migrates at 19.5 kDa on SDS-PAGE.
  • Physical form: Lyophilized from PBS with BSA as a carrier.
  • Reconstitution: Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.

Compare Similar Items

Show Difference

Img

Sigma Aldrich

SRP4975

recombinant, expressed in Saccharom...


biological source:
human

recombinant:
expressed in Saccharomyces cerevisiae

Assay:
≥98% (HPLC)≥98% (SDS-PAGE)

form:
lyophilized

mol wt:
~19.5 kDa

packaging:
pkg of 10 μg

impurities:
endotoxin, tested

NCBI accession no.:
Q13007

shipped in:
wet ice

storage temp.:
−20°C

Img

Sigma Aldrich

SRP6053

recombinant, expressed in E. coli, ...


biological source:
human

recombinant:
expressed in E. coli

Assay:
≥95% (HPLC)≥95% (SDS-PAGE)

form:
lyophilized

mol wt:
~52 kDa

packaging:
pkg of 10 μg

impurities:
__

NCBI accession no.:
P23560

shipped in:
wet ice

storage temp.:
−20°C

Img

Sigma Aldrich

SRP6054

recombinant, expressed in E. coli, ...


biological source:
human

recombinant:
expressed in E. coli

Assay:
≥95% (HPLC)≥95% (SDS-PAGE)

form:
lyophilized

mol wt:
~25 kDa

packaging:
pkg of 10 μg

impurities:
__

NCBI accession no.:
P01138

shipped in:
wet ice

storage temp.:
−20°C

Img

Sigma Aldrich

SRP6158

recombinant, expressed in HEK 293 c...


biological source:
human

recombinant:
expressed in HEK 293 cells

Assay:
≥95% (SDS-PAGE)

form:
lyophilized

mol wt:
36 kDa (monomer, glycosylated)

packaging:
pkg of 10 μg

impurities:
__

NCBI accession no.:
P01588

shipped in:
dry ice

storage temp.:
__